Status:
UNKNOWN
A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis
Lead Sponsor:
KLE Society's Institute of Dental Sciences
Conditions:
Periodontitis
Eligibility:
All Genders
20-60 years
Phase:
PHASE3
Brief Summary
The study will follow a parallel arm, randomised, double blinded, placebo controlled design. There will be two groups Group 1 = receiving 1% curcumin chips after routine scaling and root planing (n=2...
Eligibility Criteria
Inclusion
- Systemically healthy individuals
- Presence of a minimum of 20 teeth in the oral cavity
- Localised periodontal pockets with probing depths greater than 4mm i.e., Periodontitis in its stages 2 and 3, as described by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions, and published by the American Academy of Periodontology (AAP)
Exclusion
- Known allergy to curcumin and/ or hydroxyl propyl methyl cellulose
- Systemic diseases and/or Inflammatory conditions, Obesity
- Former or current tobacco users
- Chronic consumption of alcohol
- Use of anti-inflammatory drugs and antibiotics over the past 3 months
- Periodontal therapy in any form, surgical or non surgical in the past 6 months
- Pregnant and lactating mothers
Key Trial Info
Start Date :
September 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03790605
Start Date
September 4 2019
End Date
December 1 2020
Last Update
December 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
K L E society's Dental College
Bangalore, Karnataka, India, 560022